Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.50    -2.00 (-6.06%)
Bid:
31.00
Ask:
34.00
Spread: 3.00 (9.677%)
Market Cap: £56.06m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Goliath Scale-up Progress

5 Feb 2025 07:00

RNS Number : 9190V
Ilika plc
05 February 2025
 

5 February 2025

Ilika plc

('Ilika,' the 'Company,' or the 'Group')

 

Goliath Scale-up Progress

 

Key Scale-up Result from Collaboration with UKBIC

 

Ilika (AIM: IKA), the UK pioneer in solid-state battery technology, announces that its collaboration with the UK Battery Industrialisation Centre (UKBIC) has successfully demonstrated its ability to scale key steps in the manufacturing of its Goliath battery, which is expected to reduce costs, increase the range of electric vehicles and reduce their charging time.

 

This successful demonstration of manufacturing in a giga-scale factory setting, using industry standard equipment, marks another step towards commercialisation and follows progress in 2024 including the start of commercial testing, shipping of the first batch of prototype Goliath batteries to customers, and the release of validated safety data. 

 

Graeme Purdy, CEO of Ilika, said: "We are delighted with the teamwork at UKBIC, which has delivered an excellent outcome, demonstrating the large scale preparation of Goliath electrolyte and the coating of our composite electrode-electrolyte. We look forward to further collaboration on our commercialisation journey and welcome the UK government's recent announcement of £2B of funding which will catalyse faster progress in this space."

 

Sean Gilgunn, Managing Director of UKBIC, said:

"This success highlights the valuable contribution UKBIC can make to scaling up innovation in the UK's growing battery sector. Ilika's technology is a great example of the kind of cutting edge thinking which can drive the UK economy when properly supported."

 

Ilika announced in October 2023 receipt of grant support from the Automotive Transformation Fund ('ATF') in an 18-month, £2.7 million collaboration programme to scale up Ilika's Goliath solid-state battery production capability. Via the programme, Ilika partnered with Mpac Group plc ('Mpac') (AIM: MPAC) global supplier of packaging and assembly automation, UKBIC and Agratas, Tata Group's global battery business.

 

In this collaboration, codenamed Project SiSTEM, UKBIC and Ilika have carried out physical trials to demonstrate preparation and roll-to-roll coating of its proprietary solid state materials. The ongoing trials are providing evidence that Ilika's approach to large format solid-state battery manufacture can be carried out with the types of mixing and coating equipment widely used in existing gigafactories.

 

The programme activities with Mpac and Agratas are also making strong progress and remain on track. Ilika is working closely with Mpac on completing the fabrication and testing of a 1.5MWh solid-state battery assembly line capable of delivering Ilika's Goliath prototype large-format pouch cells to automotive original equipment manufacturers and Tier 1 suppliers. As stated in October 2023, the solid-state battery assembly line is expected to be fully operational at Ilika's facility by the end of H1 2025. In parallel, the activities with Agratas have produced a detailed gap analysis between Agratas's leading edge lithium-ion battery process and Ilika's process with the key result that the solid-state battery application would cause minimum disruption.

 

ENDS

 

--

Enquiries:

 

Ilika Plc Graeme Purdy, Chief Executive

Jason Stewart, Chief Financial Officer

 

www.ilika.com

Via FTI Consulting

 

Cavendish Capital Markets Limited (Nomad and Broker) Peter Lynch

Neil McDonald

 

+44 (0)131 220 9772

+44 (0)131 220 9771

 

FTI Consulting (Comms Advisors)

Ben Brewerton

Elizabeth Adams

Dwight Burden

ilika@fticonsulting.com

 

 

About Ilika plc - https://www.ilika.com

 

Ilika is a global expert in the development of solid state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.

 

The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIAFEISIIE
Date   Source Headline
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings
30th Apr 201210:22 amRNSTotal Voting Rights
25th Apr 20122:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.